Global Hemoperfusion production Market Insights, Forecast to 2025
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. In this report, we calculate medical consumables of hemoperfusion.
In 2017, China consumption volume reached 1907.5 K Units, due to the bigger demand of downstream applications and the larger population and policy support; while Europe consumed 725.4 K Units and Japan consumed 362.7 K Units.
The major raw materials for hemoperfusion are polypropylene, polycarbonate, membrane materials, activated carbon, etc. Fluctuations in the price of the upstream product will impact on the production cost of hemoperfusion, and then impact the price of hemoperfusion. The production cost of hemoperfusion is also an important factor which could impact the price of hemoperfusion.
The global Hemoperfusion production market is valued at 320 million US$ in 2018 and will reach 810 million US$ by the end of 2025, growing at a CAGR of 12.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hemoperfusion production market based on company, product type, end user and key regions.
This report studies the global market size of Hemoperfusion production in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hemoperfusion production in these regions.
This research report categorizes the global Hemoperfusion production market by top players/brands, region, type and end user. This report also studies the global Hemoperfusion production market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Jafron Biomedical
Baxter (Gambro)
Biosun Medical
Toray Medical
Asahi-Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents
Market size by Product
Resin Adsorption
Activated Carbon Adsorption
Others
Market size by End User
Overdose
Specific Intoxications
Certain Autoimmune Diseases
Hepatic Encephalopathy
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Hemoperfusion production market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hemoperfusion production market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hemoperfusion production companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hemoperfusion production submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hemoperfusion production are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hemoperfusion production market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
In 2017, China consumption volume reached 1907.5 K Units, due to the bigger demand of downstream applications and the larger population and policy support; while Europe consumed 725.4 K Units and Japan consumed 362.7 K Units.
The major raw materials for hemoperfusion are polypropylene, polycarbonate, membrane materials, activated carbon, etc. Fluctuations in the price of the upstream product will impact on the production cost of hemoperfusion, and then impact the price of hemoperfusion. The production cost of hemoperfusion is also an important factor which could impact the price of hemoperfusion.
The global Hemoperfusion production market is valued at 320 million US$ in 2018 and will reach 810 million US$ by the end of 2025, growing at a CAGR of 12.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hemoperfusion production market based on company, product type, end user and key regions.
This report studies the global market size of Hemoperfusion production in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hemoperfusion production in these regions.
This research report categorizes the global Hemoperfusion production market by top players/brands, region, type and end user. This report also studies the global Hemoperfusion production market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Jafron Biomedical
Baxter (Gambro)
Biosun Medical
Toray Medical
Asahi-Kasei
Kaneka
Zibo Kangbei
Aier
Cytosorbents
Market size by Product
Resin Adsorption
Activated Carbon Adsorption
Others
Market size by End User
Overdose
Specific Intoxications
Certain Autoimmune Diseases
Hepatic Encephalopathy
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Hemoperfusion production market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hemoperfusion production market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hemoperfusion production companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hemoperfusion production submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Hemoperfusion production are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hemoperfusion production market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
